October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
|Articles|April 18, 2022
Daily OTC Pearl: Wal-itin Loratadine Tablets
Author(s)Saro Arakelians, PharmD
Loratadine is an antihistamine that treats symptoms of allergies such as itching, runny nose, watery eyes, and sneezing.
Advertisement
OTC/Lifestyle Pearl of the Day: Wal-itin Loratadine Tablets
Indication: Loratadine is a 24-hour antihistamine that treats symptoms of allergies such as itching, runny nose, watery eyes, and sneezing.
Insight:
- Non-drowsy allergy medication.
- Works for indoor and outdoor allergies.
- Ingredients: loratadine 10 mg.
- Classified as an antihistamine.
- It comes in a tablet format.
- Provides 24 hours coverage with 1 tablet to relieve allergy symptoms.
- Take as directed and not for children.
Source:
Advertisement
Related to this article
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.
Expert Q&A: Geisinger Investigator Discusses Low Flu Vaccination Rates, ICU Findings in Older Adults
A study author explains how pharmacists can help close vaccination gaps in rural communities and what lower ICU admission rates among vaccinated older adults may mean.
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Kidney Week 2026 posters show low-density lipoprotein cholesterol (LDL-C) fell by half in patients receiving dialysis, and oral enlicitide needed no dose adjustment for renal impairment.
Walgreens adds virtual coverage navigation, Medicare GLP-1 Bridge support, and pharmacist follow-up calls as GLP-1 discontinuation remains high.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Happens Before the First Dose? 5 Steps That Shape Lung Cancer Treatment
2
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
3
Nicotine Vaping Linked to Lower Vascular Function in Young Adults
4
Full IDWeek Data Highlights 31-Valent Pneumococcal Conjugate Vaccine Candidate in Adults
5